Acute Kidney Injury aka AKI is a common problem, with serious short-term and long-term consequences. The diagnosis of AKI is frequently delayed. In the current scenario potentially effective preventive and therapeutic measures are available, but the diagnosis is frequently delayed due to lack of early predictive biomarkers. In the advent of the new biomarkers era novel technologies are providing early, non-invasive, tools for the prediction of AKI.
Currently we recognize AKI late when it becomes too late for the catch up to occur.This can be attributed to a lot of factors including delayed manifestation of clinical signs, elevation of the only “gold standard” biomarker Serum Creatinine takes a while , even the oliguria takes its own time to be recognized. All these factors leaves the mortality rates at a high. The advancements in therapies are of little help and with the…
